• The University of Western Australia (M503), 35 Stirling Highway,

    6009 Perth

    Australia

  • 3274 Citations
  • 31 h-Index
20022021
If you made any changes in Pure these will be visible here soon.

Personal profile

Biography

Dr Creaney is the Head of the Biomarkers and Discovery unit of NCARD. The group is investigating biomarkers for improved diagnosis and monitoring of patients with mesothelioma and also examining the use of biomarkers for screening asbestos-exposed individuals for early detection of mesothelioma.
Jenette received her PhD in 1995 from La Trobe University (Melbourne, Australia), and has worked in the cancer and immunology fields as a molecular biologist and protein chemist since. Jenette returned to Australia from the US in 1999 to work with Professor Bruce Robinson in Perth, on principally the marker discovery projects. The work from the group includes the seminal work on the biomarker mesothelin for use in patients with mesothelioma.
Jenette has received several prestigious awards for her work in Science including the Howard Hughes Medical Institute Postdoctoral Fellowship and a Young Investigator Award.

Research

Mesothelin – a tumour associated antigen for mesothelioma
Biomarkers for determination of drug sensitivity in mesothelioma
Next generation sequencing for malignant mesothelioma and lung cancer
Tumour immunology

Keywords

  • Cancer immunology

Fingerprint Fingerprint is based on mining the text of the person's scientific documents to create an index of weighted terms, which defines the key subjects of each individual researcher.

  • 26 Similar Profiles
Mesothelioma Medicine & Life Sciences
Neoplasms Medicine & Life Sciences
Asbestos Medicine & Life Sciences
Genes Chemical Compounds
Tumors Chemical Compounds
Atlases Medicine & Life Sciences
Genome Medicine & Life Sciences
Biomarkers Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Research Output 2002 2018

22 Citations (Scopus)

A Comprehensive Pan-Cancer Molecular Study of Gynecologic and Breast Cancers

The Cancer Genome Atlas Research Network, 9 Apr 2018, In : Cancer Cell. 33, 4, p. 690-705.e9

Research output: Contribution to journalArticle

Open Access
Breast Neoplasms
Atlases
Long Noncoding RNA
Decision Trees
Genome
35 Citations (Scopus)

An Integrated TCGA Pan-Cancer Clinical Data Resource to Drive High-Quality Survival Outcome Analytics

The Cancer Genome Atlas Research Network, 5 Apr 2018, In : Cell. 173, 2, p. 400-416.e11

Research output: Contribution to journalArticle

Open Access
Atlases
Genes
Genome
Survival
Neoplasms
13 Citations (Scopus)

A Pan-Cancer Analysis of Enhancer Expression in Nearly 9000 Patient Samples

The Cancer Genome Atlas Research Network, 5 Apr 2018, In : Cell. 173, 2, p. 386-399.e12

Research output: Contribution to journalArticle

Open Access
Genes
Tumors
Neoplasms
Computational methods
Chromatin
1 Citation (Scopus)

A Pan-Cancer Analysis Reveals High-Frequency Genetic Alterations in Mediators of Signaling by the TGF-β Superfamily

The Cancer Genome Atlas Research Network, 24 Oct 2018, In : Cell Systems. 7, 4, p. 422-437.e7

Research output: Contribution to journalArticle

Open Access
Transforming Growth Factor beta
Neoplasms
Sequence Deletion
Genes
Gastrointestinal Neoplasms
1 Citation (Scopus)

Autoimmune antibodies and asbestos exposure: Evidence from Wittenoom, Western Australia

Reid, A., Franklin, P., de Klerk, N., Creaney, J., Brims, F., Musk, B. & Pfau, J., 1 Jul 2018, In : American Journal of Industrial Medicine. 61, 7, p. 615-620 6 p.

Research output: Contribution to journalArticle

Crocidolite Asbestos
Western Australia
Asbestos
Antibodies
Indirect Fluorescent Antibody Technique

Projects 2003 2021